You are here: Home » Companies » Results
Business Standard

Cipla Q3 profit up 7% to Rs 4 bn, India revenue swells 15% to Rs 16 bn

Revenue from North America fell 2 percent due to ongoing pricing pressures in the generics market


Cipla Ltd, India's fourth-largest drugmaker by revenue, said third-quarter net profit rose 7 percent on strong domestic sales, but fell short of analysts' estimates. Net profit attributable to shareholders climbed to Rs 4.01 billion ($62.54 million) in the quarter ended Dec. 31, from Rs 3.75 billion a year earlier.  That compared with an average estimate of Rs 4.44 billion in profit drawn from 18 analysts polled by Thomson Reuters. Including a one-off positive impact of Rs 1.07 billion due to recalculation of deferred tax assets and liabilities on account of the ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, February 07 2018. 17:09 IST